🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Study on Patients With Obstructive Sleep Apnea in Hong Kong (PrOSA)

Recruitingn/aAges 18 Years - anyAllChinese University of Hong Kong
NCT04659291 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Obstructive sleep apnea syndrome (OSAS) is a common disorder with prevalence rates of at least 4% among the middle-aged male Caucasians and Hong Kong (HK) Chinese populations. It is characterized by repetitive episodes of upper airway obstruction, causing intermittent hypoxia, sleep fragmentation, disabling daytime sleepiness, impaired cognitive function and poor health status. OSAS patients are at increased risks of non-fatal and fatal cardiovascular morbidity and mortality including sudden death, in addition to being more prone to road traffic accidents. However, there is no long term follow up of patients with OSAS on the incidence of cardiovascular disease, compliance on the therapy and the impact of the quality of life. The study is aimed to carry out a prospective observational study assessing the role of OSAS as a possible cause of increased cardiovascular risk and cognitive decli

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * suspected obstructive sleep apnea syndrome * aged 18 or above * must be able to speak, read and understand Chinese or English * possess the ability to respond to questions and follow instructions. Exclusion Criteria: * already treated sleep apnea, * a limited life expectancy due to illness unrelated to sleep apnea * human immunodeficiency virus (HIV), * advanced renal disease, * uncontrolled malignancies * documented alcohol or drug abuse up to 1 year prior to inclusion in the study.
💊

What it tests

  • Not listed
📍

Where

1 site
Chinese University of Hong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy